Radiation therapy for recurrent esophageal cancer after surgery

Clinical results and prognostic factors

Yoshiyuki Shioyama, Katsumasa Nakamura, Ohga Saiji, Satoshi Nomoto, Tomonari Sasaki, Toshihiro Yamaguchi, Takashi Toba, Tadamasa Yoshitake, Hiromi Terashima, Hiroshi Honda

研究成果: ジャーナルへの寄稿記事

31 引用 (Scopus)

抄録

Objective: To evaluate the outcome of radiotherapy for recurrent esophageal cancer after surgery and to determine the prognostic factors. Methods: From 1987 through 2002, 82 patients treated with radiotherapy for loco-regional recurrences of esophageal cancer after surgery were retrospectively reviewed. The stage at initial surgery was I in 16, II in 41, III or higher in 24 and unknown in 1. The median size of recurrent tumors was 3.5 cm in diameter. Fifty-two patients were treated with radiotherapy alone, and 30 were treated with radiotherapy combined with chemotherapy. The median total dose of external radiotherapy given was 50.4 Gy in 28 fractions. Results: The median survival period after recurrence was 7.0 months. The 2- and 5-year overall survival rate for all patients was 22 and 11%, respectively. In univariate analysis, the patients with performance status (PS) = 0-1, or tumor size <3.5 cm, and those treated with total dose ≥50 Gy showed a better survival outcome than each the other groups. The patients with a history of previous radiotherapy showed a poorer survival outcome in univariate analysis than each the other groups. In multivariate analysis, tumor size, PS and radiation dose were independent prognostic factors for overall survival. Conclusion: The prognosis of patients with post-operative loco-regional recurrence of esophageal cancer is poor. However, a long-term survival may be expected by definitive radiotherapy for the patients with small-size tumors and with a good PS.

元の言語英語
ページ(範囲)918-923
ページ数6
ジャーナルJapanese journal of clinical oncology
37
発行部数12
DOI
出版物ステータス出版済み - 12 1 2007

Fingerprint

Esophageal Neoplasms
Radiotherapy
Survival
Recurrence
Neoplasms
Multivariate Analysis
Survival Rate
Radiation
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Oncology

これを引用

Radiation therapy for recurrent esophageal cancer after surgery : Clinical results and prognostic factors. / Shioyama, Yoshiyuki; Nakamura, Katsumasa; Saiji, Ohga; Nomoto, Satoshi; Sasaki, Tomonari; Yamaguchi, Toshihiro; Toba, Takashi; Yoshitake, Tadamasa; Terashima, Hiromi; Honda, Hiroshi.

:: Japanese journal of clinical oncology, 巻 37, 番号 12, 01.12.2007, p. 918-923.

研究成果: ジャーナルへの寄稿記事

Shioyama, Yoshiyuki ; Nakamura, Katsumasa ; Saiji, Ohga ; Nomoto, Satoshi ; Sasaki, Tomonari ; Yamaguchi, Toshihiro ; Toba, Takashi ; Yoshitake, Tadamasa ; Terashima, Hiromi ; Honda, Hiroshi. / Radiation therapy for recurrent esophageal cancer after surgery : Clinical results and prognostic factors. :: Japanese journal of clinical oncology. 2007 ; 巻 37, 番号 12. pp. 918-923.
@article{3c43d41461ac424cbbe0ce745e24aa1a,
title = "Radiation therapy for recurrent esophageal cancer after surgery: Clinical results and prognostic factors",
abstract = "Objective: To evaluate the outcome of radiotherapy for recurrent esophageal cancer after surgery and to determine the prognostic factors. Methods: From 1987 through 2002, 82 patients treated with radiotherapy for loco-regional recurrences of esophageal cancer after surgery were retrospectively reviewed. The stage at initial surgery was I in 16, II in 41, III or higher in 24 and unknown in 1. The median size of recurrent tumors was 3.5 cm in diameter. Fifty-two patients were treated with radiotherapy alone, and 30 were treated with radiotherapy combined with chemotherapy. The median total dose of external radiotherapy given was 50.4 Gy in 28 fractions. Results: The median survival period after recurrence was 7.0 months. The 2- and 5-year overall survival rate for all patients was 22 and 11{\%}, respectively. In univariate analysis, the patients with performance status (PS) = 0-1, or tumor size <3.5 cm, and those treated with total dose ≥50 Gy showed a better survival outcome than each the other groups. The patients with a history of previous radiotherapy showed a poorer survival outcome in univariate analysis than each the other groups. In multivariate analysis, tumor size, PS and radiation dose were independent prognostic factors for overall survival. Conclusion: The prognosis of patients with post-operative loco-regional recurrence of esophageal cancer is poor. However, a long-term survival may be expected by definitive radiotherapy for the patients with small-size tumors and with a good PS.",
author = "Yoshiyuki Shioyama and Katsumasa Nakamura and Ohga Saiji and Satoshi Nomoto and Tomonari Sasaki and Toshihiro Yamaguchi and Takashi Toba and Tadamasa Yoshitake and Hiromi Terashima and Hiroshi Honda",
year = "2007",
month = "12",
day = "1",
doi = "10.1093/jjco/hym138",
language = "English",
volume = "37",
pages = "918--923",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Radiation therapy for recurrent esophageal cancer after surgery

T2 - Clinical results and prognostic factors

AU - Shioyama, Yoshiyuki

AU - Nakamura, Katsumasa

AU - Saiji, Ohga

AU - Nomoto, Satoshi

AU - Sasaki, Tomonari

AU - Yamaguchi, Toshihiro

AU - Toba, Takashi

AU - Yoshitake, Tadamasa

AU - Terashima, Hiromi

AU - Honda, Hiroshi

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Objective: To evaluate the outcome of radiotherapy for recurrent esophageal cancer after surgery and to determine the prognostic factors. Methods: From 1987 through 2002, 82 patients treated with radiotherapy for loco-regional recurrences of esophageal cancer after surgery were retrospectively reviewed. The stage at initial surgery was I in 16, II in 41, III or higher in 24 and unknown in 1. The median size of recurrent tumors was 3.5 cm in diameter. Fifty-two patients were treated with radiotherapy alone, and 30 were treated with radiotherapy combined with chemotherapy. The median total dose of external radiotherapy given was 50.4 Gy in 28 fractions. Results: The median survival period after recurrence was 7.0 months. The 2- and 5-year overall survival rate for all patients was 22 and 11%, respectively. In univariate analysis, the patients with performance status (PS) = 0-1, or tumor size <3.5 cm, and those treated with total dose ≥50 Gy showed a better survival outcome than each the other groups. The patients with a history of previous radiotherapy showed a poorer survival outcome in univariate analysis than each the other groups. In multivariate analysis, tumor size, PS and radiation dose were independent prognostic factors for overall survival. Conclusion: The prognosis of patients with post-operative loco-regional recurrence of esophageal cancer is poor. However, a long-term survival may be expected by definitive radiotherapy for the patients with small-size tumors and with a good PS.

AB - Objective: To evaluate the outcome of radiotherapy for recurrent esophageal cancer after surgery and to determine the prognostic factors. Methods: From 1987 through 2002, 82 patients treated with radiotherapy for loco-regional recurrences of esophageal cancer after surgery were retrospectively reviewed. The stage at initial surgery was I in 16, II in 41, III or higher in 24 and unknown in 1. The median size of recurrent tumors was 3.5 cm in diameter. Fifty-two patients were treated with radiotherapy alone, and 30 were treated with radiotherapy combined with chemotherapy. The median total dose of external radiotherapy given was 50.4 Gy in 28 fractions. Results: The median survival period after recurrence was 7.0 months. The 2- and 5-year overall survival rate for all patients was 22 and 11%, respectively. In univariate analysis, the patients with performance status (PS) = 0-1, or tumor size <3.5 cm, and those treated with total dose ≥50 Gy showed a better survival outcome than each the other groups. The patients with a history of previous radiotherapy showed a poorer survival outcome in univariate analysis than each the other groups. In multivariate analysis, tumor size, PS and radiation dose were independent prognostic factors for overall survival. Conclusion: The prognosis of patients with post-operative loco-regional recurrence of esophageal cancer is poor. However, a long-term survival may be expected by definitive radiotherapy for the patients with small-size tumors and with a good PS.

UR - http://www.scopus.com/inward/record.url?scp=38749126258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38749126258&partnerID=8YFLogxK

U2 - 10.1093/jjco/hym138

DO - 10.1093/jjco/hym138

M3 - Article

VL - 37

SP - 918

EP - 923

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 12

ER -